For the ninth year running, Endocrine News talks to editors from Endocrine Society publications to unearth the endocrine nuggets of 2023. Here, the editors of the Endocrine Reviews weigh in on what they think qualify as the year’s biggest discoveries in endocrine science. The endocrine Gold Rush of ’22 from last year’s issue might have...
Author: Mark Newman
Márta Korbonits, MD, PhD, the 2023 Endocrine Society Gerald D. Aurbach Laureate Award recipient for Outstanding Translational Research, talks to Endocrine News about the award, her research on pituitary adenomas, and her own words of wisdom. Márta Korbonits, MD, PhD, is no stranger to the endocrine research community. As president of the Society for Endocrinology...
As the weather in the Washington D.C., area starts ebbing from shorts and T-shirts to jeans and hoodies, Autumn signals its arrival and therefore, the focus of Endocrine News turns to our annual diabetes research and practice issue each November, to coincide with Diabetes Awareness Month. As usual, thanks to the plethora of research on... Fresh from receiving a 2022 Endocrine Society Early Investigator Award, Estelle Everett, MD, MHS, was a member of this year’s Dimensions in Diabetes program that took place in Mumbai, India, in August. She talks to Endocrine News about that program, her own research, and how the award has impacted her career. In August 2023,...
Sage Advice: Reducing the Risk of Hypoglycemia in Older Adults with Diabetes
Hypoglycemia from overtreatment is a serious but seldom recognized complication in older adults with type 2 diabetes. A new decision support tool developed by the Endocrine Society can help primary care providers avoid overtreatment and cut the risk of hypoglycemic events in these patients. The use of a clinical decision support tool can reduce the risk...Advancing Diabetes Research and Care with Digital Education and Knowledge Sharing
More than 100 years after the discovery of insulin galvanized our field, diabetes research and care remain a central part of endocrinology. Diabetes Awareness Month offers the opportunity to reflect on the importance of our research and clinical care to millions of people around the globe. For the 540 million people worldwide living with diabetes,... Cutting-edge advancements in endocrinology continue to move diabetes treatment in the right direction faster than ever before. The treatment of diabetes is continually evolving. More than a century ago, a diabetes diagnosis was a death sentence, and although there is not yet a cure, endless updates in diabetes care help ease the burden of both...
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * FDA Approves Lilly’s Zepbound™ (tirzepatide) for Chronic Weight Management On November 8, the U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company’s (NYSE: LLY) Zepbound™ (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP (glucose-dependent insulinotropic polypeptide)...